Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Immunology dealmaking
2.1. Introduction
2.2. Immunology partnering over the years
2.3. Immunology partnering by deal type
2.4. Immunology partnering by industry sector
2.5. Immunology partnering by stage of development
2.6. Immunology partnering by technology type
2.7. Immunology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Immunology partnering
3.1. Introduction
3.2. Disclosed financials terms for Immunology partnering
3.3. Immunology partnering headline values
3.4. Immunology deal upfront payments
3.5. Immunology deal milestone payments
3.6. Immunology royalty rates

Chapter 4 - Leading Immunology deals and dealmakers
4.1. Introduction
4.2. Most active in Immunology partnering
4.3. List of most active dealmakers in Immunology
4.4. Top Immunology deals by value

Chapter 5 - Immunology contract document directory
5.1. Introduction
5.2. Immunology partnering deals where contract document available

Chapter 6 - Immunology dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Immunology therapeutic target

Appendices
Appendix 1 - Directory of Immunology deals by company A-Z 2014 to 2021
Appendix 2 - Directory of Immunology deals by deal type 2014 to 2021
Appendix 3 - Directory of Immunology deals by stage of development 2014 to 2021
Appendix 4 - Directory of Immunology deals by technology type 2014 to 2021
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures
Figure 1: Immunology partnering since 2014
Figure 2: Immunology partnering by deal type since 2014
Figure 3: Immunology partnering by industry sector since 2014
Figure 4: Immunology partnering by stage of development since 2014
Figure 5: Immunology partnering by technology type since 2014
Figure 6: Immunology partnering by indication since 2014
Figure 7: Immunology deals with a headline value
Figure 8: Immunology deals with upfront payment values
Figure 9: Immunology deals with milestone payment
Figure 10: Immunology deals with royalty rates
Figure 11: Active Immunology dealmaking activity- 2014 to 2021
Figure 12: Top Immunology deals by value since 2014

Companies mentioned
4D Pharma, 4SC, 7 Hills Pharma, 23andMe, A*STAR Agency for Science, Technology and Research, A*STAR Genome Institute of Singapore, A*STAR' Institute of Molecular and Cell Biology, Aarhus University Hospital, Aavis Pharmaceuticals, AB2 Bio, Abarca, AB Biosciences, Abbott Laboratories, Abbvie, Abcam, AbCellera, Abcuro, Abdul Latif Jameel Health, Abide Therapeutics, Abingworth Management, ABL Bio, Ablynx, Abpro, Abreos Biosciences, AbSci, Abzena, Aceso Life Science, AC Immune, Actelion, ActoGeniX, Acucela, AdAlta, Adamis Pharmaceuticals, Adaptate Biotherapeutics, Adaptive Biotechnologies, Adicet Bio, Aditx Therapeutics, Aduro BioTech, Advanz Pharma, Advaxis, Aerocrine, Aevi Genomic Medicine, Aevitas Therapeutics, Affibody, AffyXell Therapeutics, AGC Biologics, Agenus Bio, AgomAb Therapeutics, AHN Autoimmunity Institute, AIDS Clinical Trials Group, AIDS Foundation Houston, AIDS Foundation of Chicago, Aimmune Therapeutics, AirWare Labs, Ajinomoto, Akers Biosciences, Akeso Biopharma, Akoya Biosciences, Akrevia Therapeutics, Akriveia Therapeutics, Alder Biopharmaceuticals, Aldeyra Therapeutics, Alector, Alexion Pharmaceuticals, ALK-Abello, Allakos, Allegheny General Hospital, Allen Institute for Brain Science, AllerGenis, Allergopharma, Alliance for Biosecurity, Alliance for Lupus Research, Allied-Bristol Life Sciences, Alloksys Life Sciences, Almirall, Alpha Cancer Technologies, Alpine Immune Sciences, AltaVoice, Alvotech, Alzheimer's Association, AM-Pharma, Amal Therapeutics, Amegabiotech, American Diabetes Association, Amgen, AMPEL BioSolutions, Ampio Pharmaceuticals, Amunix, AnaMar, Anergis, Angiocrine Bioscience, ANI Pharmaceuticals, Annapurna Therapeutics, Anokion, Anpac Bio-Medical Science, Anthera Pharmaceuticals, Antibe Therapeutics, AntibioTx, Apeiron Biologics, Apellis Pharmaceuticals, Apocell, Applied BioMath, Aptahem, Aptar Pharma, Aptevo Therapeutics, Aptorum Group, Aqilion, Aquila BioMedical, Aralez Pharmaceuticals, Aratana Therapeutics, Arbele, Arbutus, Archer Daniels Midland Company, ArcherDX, Arcutis Biotherapeutics, Arena Pharmaceuticals, arGEN-X, argenx, Argonne National Laboratory, Ario Pharma, Armas Pharmaceuticals, Array Biopharma, Arrien Pharmaceuticals, ARS Pharmaceuticals, Artelo Biosciences, Artisan Bio, Artizan Biosciences, Asahi Kasei, Asana Biosciences, AskAt, Aslan Pharma, Astellas Pharma, Astion Pharma, AstraZeneca, Atara Biotherapeutics, ATGen Global, Atomwise, Atreca, Aurinia Pharmaceuticals, Australian Research Council, Avacta, Avactis Biosciences, Avalere Health, Avalon GloboCare, Avectas, Avid Bioservices, Avidity Biosciences, Avillion, Avrobio, Axcelead Drug Discovery Partners, Axela, AyoxxA Biosystems, Bausch & Lomb, Baxalta, Baxter International, Bayer, Bayer Animal Health, Baylor College of Medicine, B Braun, BCD Bioscience, Beacon Discovery, Beactica, Beckman Coulter, BeiGene, Beijing Yuan Jian Health Management, Bellicum Pharmaceuticals, Benaroya Research Institute, Berg, Berkeley Lights, Bertin Pharma, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Bial, Bicycle Therapeutics, Bill and Melinda Gates Foundation, Bina Technologies, Bio-Cancer Treatment International, Bio-Me, Bio-Path, Bio-Techne, BioAge Labs, BioBright, BioCad Holding, Biocartis, Biocon, bioCSL, Biocytogen, BioDuro, Biogen, Biohaven Pharmaceutical Holding, BioInvent, Bioject Medical Technologies, BiolineRX, Biolojic Design, Biomedical Advanced Research and Development Authority, BioMed X Innovation Center, Biomunex Pharmaceuticals, BioRap Technologies, BioSense Global, Biosortia Pharmaceuticals, Biotest, Biotest Pharmaceuticals, BirchBioMed, Black AIDS Institute, Blacksmith Medicines, Bleeding Disorders Foundation, Bloom Burton, Bloom Science, BlueRock Therapeutics, BlueWillow Biologics, Boehringer Ingelheim, Boston Pharmaceuticals, Botanisol, Bpifrance, Breathe Active, Brickell Biotech, Bridge Biotherapeutics, Brigham and Women's Hospital, Bright Peak Therapeutics, Brii Biosciences, Bristol-Myers Squibb, Broad Institute, Bryn Pharma, Buck Institute for Age Research, Bukwang Pharmaceuticals, BullFrog AI, C4X Discovery, Cabaletta Bio, Cadila Pharmaceuticals, Caelum Biosciences, Calico, California Institute for Regenerative Medicine, Calliditas Therapeutics, Calypso Biotech, Cambridge Enterprise, Camurus, Canadian Council, Canadian Institutes of Health Research, CANbridge Life Sciences, Cancer Genetics, Cancer Research Institute, Cannvalate, Cantargia, Carbiotix, Cardinal Partners, CareFirst BlueCross BlueShield, Carna BioSciences, Casebia Therapeutics, Catalyst Pharmaceuticals, CB2 Therapeutics, Celgene, Cellgen Diagnostics, Cell Mogrify, CellSight Technologies, Center for iPS Cells Research and Application, Centers for Disease Control and Prevention, Centogene, Central Institute for Experimental Animals, Centre Leon Berard, Centre National de la Recherche Scientifique, Centurion, Changchun High & New Technology Industries, Charite Universitatsmedizin Berlin, Charles River Laboratories, Checkpoint Therapeutics, Cheplapharm Arzneimittel, Chi-Med, Children's Hospital Boston, Chong Kun Dang, Chr Hansen, ChromaDex, Chromocell, Chugai Pharmaceutical, Chugai Pharma Marketing, Cigna Healthcare, Cipher Pharmaceuticals, Cipla, Circassia, Circuit Clinical, Circulogene, City of Hope, Clinical Ink, Clinigen, CMS Medical, Coherus Biosciences, COI Pharmaceuticals, Columbia University, Commense, Complix, Compugen, ConsortiaTX, Corbin Therapeutics, Corbus Pharmaceuticals, Corden Pharma, CoreRx Pharma, Cornell University, Corrona, Crescendo Biologics, CRISPR Therapeutics, Cristal Therapeutics, Cromos Pharma, Crown Bioscience, Crystal Bioscience, CSL Behring, CSL Plasma, CSPC Pharmaceutical Group, Cue Biopharma, Curable, Curadev Pharma, Curetis, CureVac, Cureveda, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cyclofluidic, CyDex, Cygnus, Cynata Therapeutics, Cyntar Ventures, Cynvenio, Cystic Fibrosis Foundation Therapeutics, CytoAgents, Cytobank, CytomX Therapeutics, CytoReason, Cytori Therapeutics, CytoSorbents, Cytovance Biologics, Daewoong Pharmaceutical, Daiichi Sankyo, Dako, Dalhousie University, Dana-Farber Cancer Institute, Dartmouth College, DAS Therapeutics, DBV Technologies, DecImmune Therapeutics, Defense Advanced Research Projects Agency, Denali Therapeutics, DendroCyte, Department of Defense, Dermira, Devonian Health Group, DiaCarta, Dianomi Therapeutics, Diatheva, DKSH, DNAtrix, DNX Biopharmaceuticals, Dong-A ST, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Dualogics, Duke-NUS Graduate Medical School Singapore, Duke University, Eastar Industries, Eddingpharm, Edesa Biotech, Egle Therapeutics, Eisai, Eisai Inc, Eli Lilly, Elpis Biomed, ElsaLys Biotech, Elton John AIDS Foundation, EMD Serono, Emerge Health, Emory University, Enable Biosciences, Enamine, EnBiotix, Encycle Therpaeutics, Endo Pharmaceuticals, Enesi Pharma, Ensemble Therapeutics, Enterome Bioscience, Entos Pharmaceuticals, Enumeral Biomedical, Enzychem Lifesciences, EpimAb Biotherapeutics, Epirus Biopharmaceuticals, Epivax, Equillium, Erasmus University Medical Center, Escient Pharmaceuticals, Essex Bio-Technology, eTheRNA immunotherapies, Eton Pharmaceuticals, Eurofins Discovery, Eurofins Scientific, European Bioinformatics Institute, European Union, Eutilex, Evelo Biosciences, Everest Medicines, Evommune, EVOQ Therapeutics, Evotec, Ewopharma, Exagen Diagnostics, ExeGi Pharma, Expedeon, ExScientia, F-Star, FairJourney Biologics, Federal Ministry of Health (Germany), Feinstein Institute for Medical Research, Feldan Therapeutics, Ferring Pharmaceuticals, Fibrocell Science, Five Prime Therapeutics, Fluidigm, Folia Biotech, Food Allergy Research & Education, Food and Drug Administration (FDA), Forge Therapeutics, Fortress Biotech, Foundation Medicine, Fred Hutchinson Cancer Research Center, French Alternative Energies and Atomic Energy Commission, French National Genotyping Center, French National Institute for Agricultural Research, Fresenius Kabi Pharmaceuticals, FSD Pharma, Fuji Pharma, Fundacion Progreso y Salud, G2B Pharma, Galapagos, GammaDelta Therapeutics, Gateway Hemophilia Association, GC LabCell, GE Healthcare, GEMoaB, Gencia Biotech, Genentech, GeneQuantum Healthcare, Genethon, Genfit, Genmab, Genomic Testing Cooperative, GenScript Biotech, GentiBio, Georgetown University, George Washington University, GeoVax, Gesynta Pharma, Gilead Sciences, GlaxoSmithKline, Glenmark Pharmaceuticals, Global Centers for Therapeutic Innovation, Global Stem Cell Technology, GlycoT Therapeutics, Gossamer Bio, Gradalis, Graphite Bio, Great Ormond Street Hospital (GOSH), Gritstone Oncology, Grunenthal, GT Biopharma, Guardant Health, Hadasit Medical Research Services and Development, Halfpenny Technologies, HalioDx, Halozyme Therapeutics, Hamilton Company, HanAll Pharmaceuticals, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, Hannover Medical School, Hansa Biopharma, Harbour Biomed, Harvard University, Heat Biologics, Hebrew University of Jerusalem, HemispheRx Biopharma, Hemophilia Foundation of Southern California, Henlius Biotech, HiFiBio, Highline Therapeutics, Hikma Pharmaceuticals, HitGen, Hob Diagnostics, Hoffmann La Roche, Hookipa Pharma, Horizon Pharma plc, Horizon Therapeutics, Hospices Civils de Lyon, Hospira, Hospital for Special Surgery, Hoth Therapeutics, Hualan Genetic, Humanigen, I-mab, iBio, Icahn School of Medicine at Mount Sinai, IcanoMAB, ICM, Idera Pharmaceuticals, IDIS Pharma, Idorsia, IFM Due, IFM Therapeutics, IFM Tre, Igenica, ILTOO Pharma, ImaginAb, ImCheck Therapeutics, Imcyse, IMIDomics, Immatics Biotechnologies, Immatics US, Immugenyx, ImmunArray, Immune Deficiency Foundation, Immune Design, Immuneed, Immune Pharmaceuticals, ImmuNext, Immunic, ImmunoChina Pharmaceuticals, ImmunoFlex, Immunogenesis, Immunomedics, Immunomic, Immunovia, Immunscape, ImmuPharma, IncellDx, Incyte, Indapta Therapeutics, Indee Labs, InDex Pharmaceuticals, Indigo Biosciences, Infinity Pharmaceuticals, InflamaCORE, Inmagene Biopharmaceuticals, InMed Pharmaceuticals, Innate Pharma, Innovate UK, Innovative Genomics Initiative (IGI), Innovative Targeting Solutions, Innovent Biologics, Innovus Pharmaceuticals, Inotrem, Inovalon, Inovio Pharmaceuticals, Inserm Transfert, Inspirotec, Institut Curie, Institute for Basic Science, Institute for Bioscience and Biotechnology Research, Institute for Research in Immunology and Cancer - Commercialization of Research, Institute for the Promotion of Innovation by Science and Technology in Flanders, Institute of Child Health, Institute of Human Virology, Institut Pasteur, Institut Pasteur of Shanghai at the Chinese Academy of Sciences, Intarcia Therapeutics, Integral Molecular, Integrated BioTherapeutics, Intellia Therapeutics, Intellikine, International AIDS Vaccine Initiative, Intrexon, Intrommune Therapeutics, Invitae, Ionis Pharmaceuticals, IONTAS, IP Biotech, Ipca Laboratories, iReceptor Plus, ISA Scientific, ISD Immunotech, ISIS Innovation, IsoPlexis, iTeos Therapeutics, Itus, J-Network, Jacobio Pharmaceuticals, JAGUAHR Therapeutics, Janssen Biotech, Janssen Diagnostics, Janssen Research & Development, Janssen Therapeutics, Janus Pharmaceuticals, Japan Tobacco, Jasper Therapeutics, Jazz Pharmaceuticals, JDP Therapeutics, Jeffrey Modell Foundation, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu QYuns Therapeutics, Jnana Therapeutics, Johns Hopkins Kimmel Cancer Center, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Jubilant Pharma, Jubilant Therapeutics, Juno Therapeutics, Kaken Pharmaceutical, Kalbe Genexine Biologics, Kaleido Biosciences, Kamada, Karolinska Institute, Karyopharm Therapeutics, KBI BioPharma, KBP BioSciences, Kedrion Biopharma, Keio Gijuku University, Kennedy Trust For Rheumatology Research, Kiadis Pharma, Kimberly-Clark, Kineta, King's College Hospital, Kings College London, Kiniksa Pharmaceuticals, Kissei Pharmaceutical, Kite Pharma, Klaria, Knight Therapeutics, Kobe University, KYE Pharmaceuticals, Kymab, Kymera Therapeutics, Kyverna Therapeutics, Lannett, Laurel Venture Capital, Lead Discovery Center, Lead Pharma, Leads Biolabs, Lee's Pharmaceutical, LegoChem Biosciences, Leiden University, Leidos, LEO Pharma, Les Laboratoires Servier, Leukemia & Lymphoma Society, LG Life Sciences, LifeArc, LifeMax Laboratories, Ligand Pharmaceuticals, Lipum, LNC, LogicBio Therapeutics, Lonza, Lorna Linda University, LTL Pharma, Lubeck Institute of Experimental Dermatology, Luminary Therapeutics, Luminex, Lumiphore, Lupin, Lupus Foundation of America (LFA), Lupus Research Alliance, Lupus Research Institute, Lupus Therapeutics, Lurie Children's Hospital of Chicago, Luye Pharma Group, Lynk Pharmaceuticals, MaaT Pharma, MAB Discovery, Mablife, mAbXience, Macrogenics, Macrophage Pharma, Magenta Therapeutics, Magnetic Insight, Mallinckrodt Pharmaceuticals, Mariel Therapeutics, Marinomed Biotechnologie, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Max-Planck, Maxcyte, Mayo Clinic, McGill University, MD Anderson Cancer Center, MD Biosciences, Medac, Medentech, Medical Research Council, Medical University of South Carolina, Medical University of Vienna, Medical University South Carolina, Medidata Solutions, MediGene, MedImmune, Memorial Sloan Kettering Cancer Center, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Merus, Mesoblast, Metrion Biosciences, MGC Pharma, Microbio Shanghai, Microdrop, Micro Labs, Microsoft, Midatech, MIGAL Galilee Research Institute, MilliporeSigma, Minaris Regenerative Medicine, MIODx, Miravo Healthcare, MISTR, Mitra Biotech, Mitsubishi Tanabe Pharma, Moderna Therapeutics, ModiQuest Research, Momenta Pharmaceuticals, Monash University, Morphic Therapeutic, MorphoSys, Mor Research Applications, Mount Sinai Health System, Mount Sinai Medical Center, Mount Tam Biotechnologies, Mundipharma, Munich Technical University, Mustang Bio, My Brother's Keeper, Mylan Pharmaceuticals, Mytide Therapeutics, NanoPass Technologies, NanoView Biosciences, NantWorks, Napo Pharmaceuticals, NASA, National Cancer Institute, National Heart, Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of General Medical Sciences, National Institutes of Health, National Organization for Rare Disorders, National Research Council Canada, National Science Foundation, National University of Singapore, Nature Technology, Nektar Therapeutics, Neostell, Neovacs, Neovii Pharmaceuticals, NeoX Biotech, Neptune Technologies & Bioressources, Nestle Health Science, NeuClone, Neumedicines, NeuroCycle Therapeutics, NeuroVive Pharmaceutical, Newsoara Biopharma, New Wave Ventures, New York Medical College, New York University, New York University School of Medicine, Neximmune, NextCure, Nexvet, Nichi-Iko Pharmaceutical Co, Nimbus Therapeutics, Ningbo Tai Kang Medical Technology, NJCTTQ, Nodality, Noga Therapeutics, North Carolina State University, Northwestern University, Novalere, Novant Health, Novartis, NovaSAID, Noveome Biotherapeutics, NovImmune, Novo Nordisk, Novozymes, Nuance Pharma, Nuevolution, Numab, Nurix, NYU Langone Medical Center, Oblique Therapeutics, Ocata Therapeutics, Oklahoma Medical Research Foundation, Omeros, Oncobiologics, OncoImmune, Oncologie, OncoQuest, OncoSec Medical, Onegevity, Oneness Biotech, oNKo-innate, Ono Pharmaceutical, Optimeos Life Sciences, OraSure Technologies, Orca Pharmaceuticals, Orchard Therapeutics, Orebro University, Orexo, Orifarm, Ortho-Clinical Diagnostics, Osaka University, OSE Immunotherapeutics, OSEO, Oslo University Hospital, Ospedale San Raffaele, Ossium Health, Otsuka, Owlstone Medical, Oxford University Hospitals NHS Trust, Padlock Therapeutics, Palisade Bio, Pandion Therapeutics, Panorama Research, Panther Biotechnology, Paragon Bioservices, Parvus Therapeutics, Pathios Therapeutics, PatientsLikeMe, Peking University, Pelican Therapeutics, Pendopharm, PeptiDream, Perelman School of Medicine, Pfizer, Phanes Therapeutics, PharmEste, Pharming Group, Pharmstandard, Pharnext, Philogen, Phio Pharmaceuticals, PhoreMost, Pieris, Pierre Fabre, Pinnacle Clinical Research Center, Pionyr Immunotherapeutics, Plasticell, Plexision, Pluristem Therapeutics, Pneuma Respiratory, Potenza Therapeutics, PPD, Precision BioSciences, Precision for Medicine, PredictImmune, Prestizia, PreventionGenetics, Principia Biopharma, ProBioGen, ProciseDx, Progentec Diagnostics, Project Inform, Promethera Biosciences, Prometheus Laboratories, Protagen, Prota Therapeutics, Proteona, ProThera, ProtoKinetix, Provention Bio, ProvideGx, Provider Network of America, Proximagen Group, Pulmatrix, Purdue Pharma, Pure Biologics, PureTech Health, Pyramid Biosciences, Q2 Solutions, Q32 Bio, Qiagen, Quartet Medicine, Queensland Institute of Medical Research (QIMR), Quell Therapeutics, Quest PharmaTech, R-Pharm, R-Tech Ueno, Rabin Medical Center (Beilinson Hospital), Ragon Institute, Ra Pharmaceuticals, Recipharm, Recordati, RedHill Biopharma, Regeneron Genetics Center, Regeneron Pharmaceuticals, Repertoire Genesis, Repurpose.AI, Research Foundation to Cure AIDS, RespiVert, ReveraGen BioPharma, Revive Therapeutics, Revolo Biotherapeutics, Rheonix, Rheos Medicines, Richard King Mellon Foundation, Rigel Pharmaceuticals, RIKEN Research Institute, RMX Biopharma, Roche, Rogne Bioscience, Roivant Sciences, Rosetta Genomics, Roxall, Ryvu Therapeutics, S-TARget, SAB Biotherapeutics, Salix Pharmaceuticals, Samsung Bioepis, Sangamo BioSciences, Sanofi, Sanofi-Aventis, Santhera Pharmaceuticals, Saol Therapeutics, Sartorius Stedim Biotech, SATT Lutech, Scholar Rock, Schreiner Group, Schrodinger, SciCann Therapeutics, Science Exchange, Scienion, Sciex, Scleroderma Research Foundation, Scripps Research Institute, Seagen, Sean N Parker Center for Allergy Research, Seattle Children's Hospital, Seattle Childrens Research Institute, Seattle Genetics, Second Genome, SecondWave Systems, Sekris Biomedical, Selecta Biosciences, Selecxine, Selexis, Sementis, Sengenics, SenzaGen, Seqirus, Serametrix, SeraNovo, Seres Therapeutics, Serum Institute of India, Sevion Therapeutics, Shandong Fontacea Pharmaceutical, Shanghai Model Organisms Center, Shattuck Labs, Shin Nippon Biomedical Laboratories, Shire Laboratories, Shire Pharmaceuticals, Sigma-Tau, Sigmoid, Silence Therapeutics, Simbec Research, Simcere Pharmaceuticals, Singota Solutions, Siolta Therapeutics, Sirona Biochem, Sitryx, Skyhawk Therapeutics, SomaLogic, Sonora Quest Laboratories, Sorrento Therapeutics, Sosei, Sosei Heptares, Splicos, Spring Bank Pharmaceuticals, SQI Diagnostics, St. Jude Children's Research Hospital, STADA Arzneimittel, Stallargenes, Stanford University, Stanford University School of Medicine, Stellar Biotechnologies, Stony Brook University, Stryker, Sutro Biopharma, Swedish Orphan Biovitrum, Swiss Commission for Technology and Innovation, Swixx Biopharma, Sygnature Discovery, Symbiotix Biotherapies, Symphogen, Synedgen, Synthekine, Synthorx, Takeda Pharmaceutical, Takeda Ventures, Tango Therapeutics, Targeted Medical Pharma, Tavotek Biotherapeutics, Teijin, Tel Aviv Sourasky Medical Center, Telix Pharmaceuticals, TeneoBio, Tennessee Hemophilia, Terumo BCT, Tessa Therapeutics, Tetra Bio-Pharma, Tetragenetics, Teva Pharmaceutical Industries, TG Therapeutics, The Elizabeth Taylor AIDS Foundation, The Hospital for Sick Children, The Innovation Fund, The International AIDS Vaccine Initiative, The Myositis Association, The Parker Institute For Cancer Immunotherapy, Theradiag, Therapix Bio, Theravance Biopharma, Thermo Fisher Scientific, Thomas Jefferson University, Thorne Research, Tiziana Life Sciences, Tizona Therapeutics, T Med, Tmunity Therapeutics, Topas Therapeutics, Tow Foundation, Traaser, TransBio, Transgene, Transimmune, TransThera, TrialSpark, Triumvira Immunologics, True Diagnostics, True North Therapeutics, Tsinghua University, Tufts Medical Center, Turgut Ilaclari, Twist Bioscience, TxCell, Ubiquigent, UCB, Ultimovacs, UMF, Unilife, University College London, University Health Network, University of Alberta, University of Arizona, University of British Columbia, University of Calgary, University of California, San Diego, University of California Berkeley, University of California Los Angeles, University of California San Francisco, University of Cambridge, University of Chicago, University of Cincinnati, University of Colorado, University of Connecticut, University of Debrecen, University of Dundee, University of Edinburgh, University of Florida, University of Geneva, University of Houston, University of Kiel, University of KwaZulu-Natal, University of Lethbridge, University of Manchester, University of Maryland School of Medicine, University of Massachusetts, University of Massachusetts, Amherst, University of Massachusetts Medical School, University of Michigan, University of Minnesota, University of Mississippi, University of Montreal, University of Natural Resources and Life Sciences, University of New South Wales, University of North Texas Health Science Center, University of Oxford, University of Pennsylvania, University of Queensland, University of Sheffield, University of Sherbrooke, University of South Carolina, University of Texas Southwestern Medical Center, University of Toronto, University of Utah, University of Verona, University of Virginia, University of Washington, University of West Indies, University of Wisconsin-Madison, University of Zurich, Uppsalagruppen Medical, Upsher-Smith, Valneva, Vanderbilt University, Variant Pharmaceuticals, Vedanta Biosciences, Velocity Pharmaceutical Development, Verily, ViaMune, Viela Bio, Vifor-Fresenius Medical Care Renal Pharma Ltd, Vinnova, Vitaeris, Vital Therapies, Vitesse Biologics, Vium, Vividion Therapeutics, Vivoryon Therapeutics, Voluntis, vTv Therapeutics, Vycellix, Washington State University, Watson Laboratories, Weill Cornell Medical College, Wellcome Trust Sanger Institute, WellGen, Willow Biosciences, Windgap Medical, Wisconsin Alumni Research Foundation, Worldwide Clinical Trials, Wuhan Kindstar Diagnostics, WuXi Biologics, WuXi NextCODE Genomics, X-chem, X4 Pharmaceuticals, Xencor, Xilio Therapeutics, XL-Protein, Xoma, XTL Biopharmaceuticals, Y-Biologics, Yale University, Yangtze River Pharmaceutical Group, Yeda Research and Development Company, Yisheng Biopharma, Yissum Research Development, ZAI Laboratory, Zealand Pharma, Zebra Biologics, Zenoaq, Zenyaku Kogyo, Ziopharm Oncology, Zylo Therapeutics, Zymeworks, ZyVersa Therapeutics